Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia

B. R. Wamhoff, J. L. Dixon, M. Sturek

Research output: Contribution to journalReview articlepeer-review

34 Scopus citations

Fingerprint Dive into the research topics of 'Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca<sup>2+</sup> signaling in diabetic dyslipidemia'. Together they form a unique fingerprint.

Medicine & Life Sciences